Open AccessUsing real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand
Author(s) -
Krittimeth Trerayapiwat,
Peerawat Jinatongthai,
Prin Vathesatogkit,
Piyamitr Sritara,
Ninutcha Paengsai,
Piyameth Dilokthornsakul,
Surakit Nathisuwan,
L Le,
Nathorn Chaiyakunapruk
Publication year - 2022
Publication title -
the lancet regional health - western pacific
Language(s) - English
Resource type - Journals
ISSN - 2666-6065
DOI - 10.1016/j.lanwpc.2022.100503
Subject(s) - tenecteplase , medicine , streptokinase , thrombolysis , myocardial infarction , percutaneous coronary intervention , fibrinolytic agent , quality adjusted life year , cost effectiveness analysis , cost effectiveness , mortality rate , emergency medicine , intensive care medicine , tissue plasminogen activator , risk analysis (engineering)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom